In hypertensive subjects, cardiovascular event risk reduction is mainly associated with the normalization of systolic blood pressure.
Does antihypertensive therapy reduce cardiovascular event risk and arterial stiffness in hypertensive subjects?
Cardiovascular event risk reduction in hypertensive subjects is mainly associated with the normalization of systolic blood pressure.
Importance of the field: There is no doubt as to the existence of a significant relationship between the pulsatile blood pressure component and cardiovascular risk. In hypertensive subjects, cardiovascular event risk reduction is mainly associated with the normalization of systolic blood pressure. Systolic blood pressure and pulse pressure in the ascending aorta exceeds brachial systolic and pulse pressure significantly.
Safar et al. (Wed,) conducted a review in Hypertension. Antihypertensive therapy was evaluated. In hypertensive subjects, cardiovascular event risk reduction is mainly associated with the normalization of systolic blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: